CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
481-495 of 959
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
MinuteCE®Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
MinuteCE®Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
MinuteCE®Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
MinuteCE®Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CEEnhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
- advertisement
Chairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
CME/CEChairperson Perspective: Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates
First-line Chemotherapy Options in Metastatic PDAC
MinuteCE®First-line Chemotherapy Options in Metastatic PDAC
Second-line Chemotherapy Options in Metastatic PDAC
MinuteCE®Second-line Chemotherapy Options in Metastatic PDAC
Chairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma
CME/CEChairperson Perspective: Core Concepts for Community-Based Practice: The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
CME/CERevolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
- advertisement
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CETreatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
MinuteCE®Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
